logo-loader
viewPressure BioSciences, Inc.

Pressure Biosciences delighted at collaborator's recognition

Aebersold received the Karger Medal from the Barnett Institute of Chemical & Biological Analysis in Boston, Masachusetts.

award.jpg
The award recognises an individual who 'significantly contributed' to the development of new bioanalytical methods

Pressure Biosciences Inc (OTCMKTS:PBIO), the lab instrumenation specialist, said collaborator Dr Ruedi Aebersold, has been recognised in a prestigious bioanalytics award scheme.

Aebersold received the Karger Medal from the Barnett Institute of Chemical & Biological Analysis in Boston, Masachusetts.

It recognizes an individual who has 'significantly contributed' to the development of new bioanalytical methods.

As part of the ceremony, Dr Aebersold presented two seminars, which highlighted his research in proteomics - the study of the entire set of proteins produced by healthy and diseased cells.

Both lectures included slides describing his use of Pressure BioSciences' novel, award winning, next-generation Barocycler 2320EXTREME for proteomic sample preparation in biomarker discovery and other research applications.

Quoting from the lectures, the firm said the doctor explained: "Not only do we need to consider the method of analyzing the proteome, we must also recognize that the method of sample preparation used for extraction and digestion of proteins is equally important to achieve a high degree of reproducibility of research results."

In 2015, Dr Aebersold and Dr Tiannan Guo collaborated with Pressure scientists and engineers to develop PCT-SWATH, a sample preparation and analysis method that combines the firm's sample preparation platform with SCIEX's SWATH-MS-based proteomics workflow.

PCT-SWATH is also notably employed by ProCan, a cancer research initiative at the Children's Medical Research Institute in Australia, which is also an NCI Cancer Moonshot collaborator.

Vice president of marketing and sales at Pressure BioSciences Dr Nate Lawrence, said: "We are delighted that Dr. Aebersold has again been recognized for his groundbreaking research in proteomics.

"We are honored to be both his colleague and collaborator in the development of instrumentation and methods essential in the preparation of samples for the discovery of protein biomarkers and other important applications.

"We look forward to working with Professor Aebersold and his team for years to come."

Shares in New York rose almost 6% to $6.99 each.

Quick facts: Pressure BioSciences, Inc.

Price: 1.95 USD

OTCMKTS:PBIO
Market: OTCQB
Market Cap: $6 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Pressure BioSciences, Inc. named herein, including the promotion by the Company of Pressure BioSciences, Inc. in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

2 min read